About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Jan 19, 2021... Prof. Karina Yaniv, Department of Biological Regulation, explains why it is so important to understand embryonic development. Across life forms, development is similar; in fact, it can be hard to distinguish between embryos from different species...
https://weizmann-usa.org/news-media/feature-stories/february-is-american-heart-month-2/
Feb 10, 2021...
Covid-19 is now, by some measures, the leading cause of death in the U.S., surpassing heart disease. Yet not only is heart disease not going away, its rates are expected to increase due to Covid; as the American Heart Association recently reported, Covid’s influence “will directly and indirectly impact rates of cardiovascular disease prevalence and deaths for years to come.”
While coronavirus research at the Weizmann Institute of Science continues full speed ahead, so does critical work on heart disease. February is American Heart Month, so we’d like to share current Weizmann Institute research on this most celebrated organ.
May 25, 2022...
REHOVOT, ISRAEL – May 25 2022 – Our family origins tend to shape our future in many ways. A Weizmann Institute of Science study, published today in Nature, found that the same holds true for blood vessels. The researchers discovered blood vessels forming from unexpected progenitors and went on to show that this unusual origin determines the vessels’ future function.
“We found that blood vessels must derive from the right source in order to function properly – it’s as if they remember where they came from,” says team leader Prof. Karina Yaniv.
https://weizmann-usa.org/news-media/news-releases/treating-a-heart-attack-before-it-happens/
Mar 08, 2023...
REHOVOT, ISRAEL—March 8, 2023— Imagine getting treatment for a perfectly healthy young heart that would allow it to recover from an otherwise devastating injury decades later.
If you think this prospect seems farfetched, you are not alone. Until recently, Prof. Eldad Tzahor, whose lab at the Weizmann Institute of Science studies heart tissue regeneration, had also considered it science fiction. After all, cardiovascular diseases, which are humanity’s leading cause of death, aren’t generally perceived as something one can prepare for through preventive treatment. But Tzahor and researchers in his lab have now activated a cellular mechanism in healthy mouse hearts that makes these mice resilient to future heart attacks – even when they occur months later.
©2023 American Committee for the Weizmann Institute of Science
